These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36558195)

  • 1. Coumarin-Induced Hepatotoxicity: A Narrative Review.
    Pitaro M; Croce N; Gallo V; Arienzo A; Salvatore G; Antonini G
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?
    Farinola N; Piller NB
    Pharmacogenomics; 2007 Feb; 8(2):151-8. PubMed ID: 17286538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for Avoiding Benzopyrone Hepatotoxicity in Lymphedema Management-The Role of Pharmacogenetics, Metabolic Enzyme Gene Identification, and Patient Selection.
    Hu M; Piller NB
    Lymphat Res Biol; 2017 Dec; 15(4):317-323. PubMed ID: 29087786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone).
    Cox D; O'Kennedy R; Thornes RD
    Hum Toxicol; 1989 Nov; 8(6):501-6. PubMed ID: 2591993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coumarin-induced hepatotoxicity.
    Loprinzi CL; Sloan J; Kugler J
    J Clin Oncol; 1997 Sep; 15(9):3167-8. PubMed ID: 9294482
    [No Abstract]   [Full Text] [Related]  

  • 6. Species differences in the metabolism and hepatotoxicity of coumarin.
    Fentem JH; Fry JR
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Jan; 104(1):1-8. PubMed ID: 8097443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin.
    Adam BS; Pentz R; Siegers CP; Strubelt O; Tegtmeier M
    Phytomedicine; 2005 Jan; 12(1-2):52-61. PubMed ID: 15693708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lympidem (a coumarin derivative) induced reversible hepatotoxicity in an adult Sri Lankan.
    Satarasinghe RL; Jayawardana MA
    Drug Metabol Drug Interact; 2009; 24(1):89-94. PubMed ID: 19354003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats.
    Murat Bilgin H; Atmaca M; Deniz Obay B; Ozekinci S; Taşdemir E; Ketani A
    Exp Toxicol Pathol; 2011 May; 63(4):325-30. PubMed ID: 20207117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk prediction of hepatotoxicity in paracetamol poisoning.
    Wong A; Graudins A
    Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the disposition, metabolism and hepatotoxicity of coumarin in the rat and Syrian hamster.
    Lake BG; Evans JG; Chapuis F; Walters DG; Price RJ
    Food Chem Toxicol; 2002 Jun; 40(6):809-23. PubMed ID: 11983276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity.
    Vassallo JD; Hicks SM; Daston GP; Lehman-McKeeman LD
    Toxicol Sci; 2004 Aug; 80(2):249-57. PubMed ID: 15141102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of coumarin hepatotoxicity.
    Casley-Smith JR; Casley-Smith JR
    Med J Aust; 1995 Apr; 162(7):391. PubMed ID: 7715532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute cytolytic hepatitis caused by coumarin. 2 cases].
    Koch S; Beurton I; Bresson-Hadni S; Monnot B; Hrusovsky S; Becker MC; Vanlemmens C; Carbillet JP; Miguet JP
    Gastroenterol Clin Biol; 1997; 21(3):223-5. PubMed ID: 9161499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain-specific enhancement or inhibition of coumarin hepatotoxicity in mice following pretreatment with two different liver enzyme-inducing agents.
    Cottrell S; Oliver K; Lake BG; Powell CJ
    Fundam Appl Toxicol; 1996 Nov; 34(1):47-55. PubMed ID: 8937891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema.
    Farinola N; Piller N
    Lymphat Res Biol; 2005; 3(2):81-6. PubMed ID: 16000056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans.
    Uehara T; Kiyosawa N; Shimizu T; Omura K; Hirode M; Imazawa T; Mizukawa Y; Ono A; Miyagishima T; Nagao T; Urushidani T
    Hum Exp Toxicol; 2008 Jan; 27(1):23-35. PubMed ID: 18480146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and risk assessment of coumarin: focus on human data.
    Abraham K; Wöhrlin F; Lindtner O; Heinemeyer G; Lampen A
    Mol Nutr Food Res; 2010 Feb; 54(2):228-39. PubMed ID: 20024932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
    Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR
    Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.